A recent global study analyzing vaccine data from 99 billion individuals across eight countries sheds light on the impact of COVID-19 vaccines on health. The findings indicate a slight increase in neurological, blood, and heart-related disorders among vaccine recipients.
According to the research, individuals receiving three doses of Pfizer-BioNTech or mRNA vaccines may experience a slight uptick in a condition known as Eo Khadem. Additionally, those opting for the AstraZeneca vaccine face a heightened risk of pericarditis after the first and fourth doses.
The study reveals that Moderna recipients face a sevenfold and 2.64 increased risk of pericarditis with the first and fourth doses, respectively. AstraZeneca users have an elevated risk of developing the neurological disorder Guillain-Barré syndrome, with a 6.94-fold increase. For blood clots, the double-dose vaccine carries a 3.8 times higher risk of acute disseminated encephalomyelitis.
While the study acknowledges the need for further investigation into several disorders, it emphasizes that the risk of these conditions remains very small. Out of 13 billion vaccine administrations, only around 2000 cases have been reported.
Despite these rare findings, the study underscores the overall benefits of COVID-19 vaccines, asserting that the advantages far outweigh the minimal risks associated with specific health conditions. Stay informed for more updates on this evolving global health scenario
mustakimsajib007
1 thought on “New Study Unveils Rare Health Impacts of COVID-19 Vaccines Worldwide”